Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

EJNMMI Research

N. Bird¹  I. A. Mendichovszky²  Y. L. Rimmer³  M. I. Ross⁴ 

[1] Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, CB2 0QQ, Cambridge, UK;Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, CB2 0QQ, Cambridge, UK;Department of Radiology, University of Cambridge, Cambridge Biomedical Campus, Hills Road, CB2 0QQ, Cambridge, UK;Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Hills Road, CB2 0QQ, Cambridge, UK;Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, CB2 0QQ, Cambridge, UK;School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Hills Road, CB2 0QQ, Cambridge, UK;

关键词: [Ga]Ga-THP-PSMA;    Prostate;    Cancer;    Carcinoma;    Metastasis;    Cerebral;    Brain;    Solitary;    PET/CT;   

DOI  :  10.1186/s13550-020-00696-0

来源: Springer

【 摘 要 】

BackgroundBrain metastases from prostate cancer are rare and usually only occur in the context of widespread systemic disease. This is the first case report of a solitary brain oligometastasis, in a neurologically intact prostate cancer patient with no other systemic disease, detected using [68Ga]Ga-THP-PSMA PET/CT and only the second one using a PSMA-based radiopharmaceutical.Case presentationWe report the case of a prostate cancer patient presenting 5 years after robot-assisted laparoscopic prostatectomy with biochemical recurrence, no neurological symptoms, and in the absence of metastatic lesions in the body on conventional imaging. A solitary cerebral metastasis was detected using [68Ga]Ga-THP-PSMA PET/CT, surgically resected, leading to a drop in serum PSA and a good recovery.ConclusionIn this case, [68Ga]Ga-THP-PSMA PET/CT resulted in a major change in clinical management and avoided additional morbidity associated with delayed diagnosis and treatment. This report demonstrates the importance of considering the presence of metastatic disease outside the conventional locations of prostate cancer spread, as well as the importance of ensuring comprehensive [68Ga]Ga-PSMA PET/CT coverage from vertex to upper thighs.

【 授权许可】

CC BY